Home › Funds › NEA Management Company, LLC › XFOR

NEA Management Company, LLC position in XFOR

X4 PHARMACEUTICALS INC · Health Care

NEA Management Company, LLC reported holding 3,233,743 shares of XFOR (X4 PHARMACEUTICALS INC) in its Q2 2026 13F filing — a position valued at US$15.1M, representing 0.95% of its reported portfolio and ranking #14 among its reported holdings. NEA Management Company, LLC has disclosed XFOR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

Latest position (Q2 2026)3.23M sh
Reported value held$15.10M
Portfolio Weight0.95%
First reportedQ3 2023
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How NEA Management Company, LLC's XFOR position evolved

NEA Management Company, LLC first disclosed a stake in XFOR in Q3 2023 at 14,986,793 shares (US$16.3M). The position peaked in Q1 2024 at 14,986,793 shares, worth US$20.8M. Across 12 filings, NEA Management Company, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 8 time(s). The most recent filing (Q2 2026) shows 3,233,743 shares valued at US$15.1M. Notable position changes include a 97% trim in Q2 2025 (shares rose 80% over the following quarter), a 347% increase in Q3 2025 (shares rose 17% over the following quarter), a 45% increase in Q4 2025 (shares rose 3% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q3 2023 14.99M $16.34M New
Q4 2023 14.99M $12.57M Hold
Q1 2024 14.99M $20.83M Hold
Q2 2024 14.99M $8.69M Hold
Q3 2024 14.99M $10.04M Hold
Q4 2024 14.99M $10.99M Hold
Q1 2025 14.99M $3.54M Hold
Q2 2025 499.56K $949.16K Reduce
Q3 2025 2.23M $7.64M Add
Q4 2025 3.23M $12.93M Add
Q1 2026 3.23M $13.36M Hold
Q2 2026 3.23M $15.10M Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About XFOR and 13F data

XFOR (X4 PHARMACEUTICALS INC) is a Health Care company. 40 other funds we track also report a position in XFOR — the largest reported positions include Bain Capital Life Sciences Investors, LLC (US$37.2M), PERCEPTIVE ADVISORS LLC (US$37.0M), Saturn V Capital Management LP (US$32.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding XFOR

All XFOR fund holders →

FAQ

How long has NEA Management Company, LLC held XFOR?

NEA Management Company, LLC has disclosed XFOR holdings in 12 of the last 12 reported quarters, going back to Q3 2023.

What is NEA Management Company, LLC's current position in XFOR?

As of Q2 2026, NEA Management Company, LLC holds 3.23M shares of XFOR (X4 PHARMACEUTICALS INC), valued at $15.10M, representing 0.95% of its reported portfolio and ranking #14.

Has NEA Management Company, LLC been buying or selling XFOR?

In the latest 13F filing (Q2 2026), NEA Management Company, LLC held unchanged its position in XFOR. The position peaked in Q1 2024 at 14.99M shares.

Which other funds hold XFOR?

Other major institutional holders of XFOR include Bain Capital Life Sciences Investors, LLC, PERCEPTIVE ADVISORS LLC, Saturn V Capital Management LP, among 40 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.